Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-14
DOI
10.1186/s13287-021-02309-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation “MSC-FFM”—Outcome Report of 92 Patients
- (2019) Halvard Bonig et al. Cells
- Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease
- (2018) Julián Panés et al. GASTROENTEROLOGY
- Mesenchymal Stromal Cell Therapy for Solid Organ Transplantation
- (2018) Marlies E. J. Reinders et al. TRANSPLANTATION
- Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
- (2018) Matthew Li et al. Scientific Reports
- Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs
- (2015) John Girdlestone et al. CYTOTHERAPY
- SOCS1 Regulates the Immune Modulatory Properties of Mesenchymal Stem Cells by Inhibiting Nitric Oxide Production
- (2014) Lei Zhang et al. PLoS One
- The interaction between mesenchymal stem cells and steroids during inflammation
- (2014) X Chen et al. Cell Death & Disease
- Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
- (2014) James A. Ankrum et al. Scientific Reports
- Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
- (2013) Joanne Kurtzberg et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
- (2013) Jacques Galipeau CYTOTHERAPY
- Cyclosporin A Inhibits Rotavirus Replication and Restores Interferon-Beta Signaling Pathway In Vitro and In Vivo
- (2013) Zigang Shen et al. PLoS One
- Human mesenchymal stem cells suppress donor CD4+T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease
- (2012) L. M. Tobin et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mechanisms of mesenchymal stromal cell immunomodulation
- (2012) Karen English IMMUNOLOGY AND CELL BIOLOGY
- Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes
- (2010) J.-P. Liu et al. Transplant Infectious Disease
- Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells
- (2009) F. Buron et al. TRANSPLANTATION PROCEEDINGS
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
- IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
- (2008) David Polchert et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now